Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation
Keywords: مینوسایکلین; diabetes mellitus; minocycline; β-amyloid protein; NF-κB